Redefining Obesity: Advancing Care for Better Lives

Take Home

The Lancet Diabetes & Endocrinology Commission redefines obesity by distinguishing clinical obesity (a chronic disease state caused by excess adiposity leading to organ dysfunction) from preclinical obesity (excess adiposity without current organ dysfunction but with increased health risks). This new framework moves beyond BMI as the sole diagnostic criterion, incorporating additional measures like waist circumference and waist-to-hip ratio. The goal is to improve patient care, refine treatment strategies, and prioritize interventions based on individual risk.

Background

Obesity affects nearly an eighth of the world’s population, yet its diagnosis has relied primarily on BMI, which does not account for metabolic health. The Commission, composed of 58 international experts, developed a classification system to improve diagnostic accuracy and guide treatment. By recognizing clinical obesity as a disease state with specific organ dysfunction, the framework aims to enhance patient outcomes and inform healthcare policies.

Research Method

The Commission reviewed existing obesity classifications, epidemiological data, and clinical outcomes. A Delphi consensus process with global experts established diagnostic criteria, incorporating patient perspectives and scientific evidence. The framework was endorsed by over 75 medical organizations worldwide.

Results

• Clinical Obesity vs. Preclinical Obesity:
  • Clinical Obesity: Defined by excess adiposity causing dysfunction in organs/tissues, leading to conditions like heart failure, sleep apnea, or liver disease.
  • Preclinical Obesity: Characterized by excess adiposity but preserved organ function, with an increased risk of disease progression.
• New Diagnostic Approach:
  • BMI is not sufficient for diagnosis—excess adiposity must be confirmed by at least one other measure (e.g., waist circumference, waist-to-hip ratio).
  • Clinical Obesity Diagnosis: Requires confirmed obesity status plus evidence of organ dysfunction or functional limitations in daily activities.
• Treatment Implications:
  • Clinical obesity requires timely interventions (lifestyle, medication, or surgery) to prevent organ damage.
  • Preclinical obesity is managed with risk reduction strategies, not necessarily medical treatment.

Practical Application

• Updated Patient Assessment: Clinicians should incorporate waist circumference and waist-to-hip ratio alongside BMI to improve obesity diagnosis.
• Treatment Personalization: Management plans should be tailored based on whether a patient has preclinical or clinical obesity.
• Healthcare Policy Impact: Insurance and healthcare systems may need to update coverage policies to ensure timely access to treatments.
• Patient Communication: Physicians should shift conversations from BMI alone to a broader assessment of metabolic and organ health, reducing weight-based stigma.
• Clinical Guidelines & Training: Professional organizations may need to revise diagnostic criteria and ensure healthcare providers are trained in this updated approach.

By integrating this framework into practice, clinicians can provide more precise, evidence-based obesity care, improving long-term patient outcomes while avoiding overdiagnosis or underdiagnosis.

‍

Decision Flowchart for Obesity Assessment

Here's a visual breakdown of the obesity classification and treatment decision-making process:

1. BMI Measurement (Screening)
   • BMI ≥30 kg/m² (or ethnicity-specific threshold) → Proceed to next step
   • BMI <30 kg/m² → No further obesity-specific intervention unless other risk factors present
2. Confirm Excess Adiposity
   • Measure waist circumference, waist-to-hip ratio, or body fat percentage
   • If excess adiposity confirmed → Continue assessment
   • If not confirmed → Consider alternative diagnosis
3. Evaluate for Clinical Obesity
   • Check for organ dysfunction (metabolic, respiratory, cardiovascular, musculoskeletal, reproductive)
   • Check for limitations in daily living (mobility, ADLs)
   • If organ dysfunction or functional impairment present → Diagnose Clinical Obesity
   • If absent → Diagnose Preclinical Obesity
4. Treatment Approach
   • Clinical Obesity → Active intervention (lifestyle, medication, surgery as needed)
   • Preclinical Obesity → Risk reduction strategies, monitoring

How to Use This in Practice

• Instead of relying on BMI alone, confirm obesity status using additional measures.
• If clinical obesity is diagnosed, treatment should focus on organ protection, symptom relief, and weight reduction.
• If preclinical obesity is identified, focus on preventing progression with targeted lifestyle and medical interventions.
• Use a multidisciplinary approach: Refer to dietitians, endocrinologists, cardiologists, or physical therapists as needed.

‍

‍